2229 GMT - Crop-chemicals supplier Nufarm may have made its task of extracting value from its Seed Technologies business harder, suggests Jefferies. Nufarm has changed how it reports on operating businesses within its portfolio. It will now include seed treatment within its Crop Protection division, rather than within Seed Technologies as before. Seed treatment made A$20.5 million of Ebitda in FY 2024. In response, Jefferies cuts its Seed Technologies FY 2025 Ebitda forecast to A$2 million, from A$20 million. "The reclassification of a significant part of the Seeds earnings is unhelpful in obtaining an attractive outcome for the business in our view," analyst Ramoun Lazar says. (david.winning@wsj.com; @dwinningWSJ)
(END) Dow Jones Newswires
November 16, 2025 17:29 ET (22:29 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.